XML 17 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income
Balance, beginning balance at Dec. 31, 2014 $ 161,554 $ 59,389 $ 99,816 $ 2,349
Balance, beginning period (in shares) at Dec. 31, 2014   10,724,359    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 4,175   4,175  
Net unrealized gain on securities available for sale, net of tax 57     57
Net unrealized loss on securities transferred from available for sale to held to maturity, net of tax (19)     (19)
Comprehensive income 4,213   4,175 38
Cash dividends declared (2,255)   (2,255)  
Equity compensation expense 74 $ 74    
Payment to repurchase common stock (180) $ (180)    
Payment for repurchase of common stock (in shares)   (10,138)    
Issuance of restricted stock (in shares)   13,650    
Proceeds from sale of common stock 110 $ 110    
Proceeds from sale of common stock (in shares)   6,548    
Balance, ending period at Mar. 31, 2015 $ 163,516 $ 59,393 101,736 2,387
Balance, ending balance (in shares) at Mar. 31, 2015 10,734,419 10,734,419    
Balance, beginning balance at Dec. 31, 2015 $ 167,498 $ 59,970 106,673 855
Balance, beginning period (in shares) at Dec. 31, 2015 10,753,855 10,753,855    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income $ 4,503   4,503  
Net unrealized gain on securities available for sale, net of tax 1,852     1,852
Net unrealized loss on securities transferred from available for sale to held to maturity, net of tax (11)     (11)
Comprehensive income 6,344   4,503 1,841
Cash dividends declared (2,370)   (2,370)  
Equity compensation expense 49 $ 49    
Payment to repurchase common stock (129)   (129)  
Payment for repurchase of common stock (in shares)   (6,936)    
Tax benefit from vesting of restricted stock 32 $ 32    
Issuance of restricted stock (in shares)   21,847    
Proceeds from sale of common stock 121 $ 121    
Proceeds from sale of common stock (in shares)   6,541    
Balance, ending period at Mar. 31, 2016 $ 171,545 $ 60,172 $ 108,677 $ 2,696
Balance, ending balance (in shares) at Mar. 31, 2016 10,775,307 10,775,307